In vitro, silencing of TEAD4 in prostate cancer cells significantly inhibited cell growth (Fig. 7f for CWR22Rv1 and Supplementary Fig. 1g for PC3) and increased the cell doubling time (Fig. 7g). This evidence concerns the gene TEAD4 and prostate cancer.